Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
687.50
572.60
627.70
622.10
590.20
515.30
515.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
687.50
572.60
627.70
622.10
590.20
515.30
515.20
Raw Material Cost
11.30
9.20
15.50
13.60
15.60
12.80
13.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
49.70
80.20
1.10
Selling and Distribution Expenses
286.30
276.50
287.80
234.30
242.00
243.10
218.90
Other Expenses
24.43
26.32
17.94
18.94
13.50
7.39
13.15
Total Expenditure (Excl Depreciation)
541.90
548.90
482.70
437.30
442.30
410.00
364.90
Operating Profit (PBDIT) excl Other Income
145.6
23.700000000000003
145
184.8
147.89999999999998
105.3
150.29999999999998
Other Income
20.60
21.70
22.50
23.40
22.80
23.40
20.00
Operating Profit (PBDIT)
173.50
53.00
174.60
214.70
178.00
134.90
176.00
Interest
0.00
0.00
0.00
0.00
49.70
80.20
1.10
Exceptional Items
-6.70
-30.70
-4.90
-17.90
-22.40
-14.00
29.00
Gross Profit (PBDT)
676.20
563.40
612.20
608.50
574.60
502.50
501.80
Depreciation
7.30
7.60
7.10
6.50
7.30
6.20
5.70
Profit Before Tax
159.50
14.70
162.60
190.30
98.60
34.50
198.20
Tax
52.00
6.80
59.50
60.50
33.60
-8.90
50.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
107.50
7.90
103.10
129.80
65.00
43.40
147.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
107.50
7.90
103.10
129.80
65.00
43.40
147.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
107.50
7.90
103.10
129.80
65.00
43.40
147.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,694.30
2,535.70
2,589.70
2,718.90
2,509.20
2,386.10
2,232.00
Earnings per share (EPS)
1.06
0.08
1.0
1.24
0.63
0.42
1.44
Diluted Earnings per share
1.06
0.08
1.0
1.24
0.63
0.42
1.44
Operating Profit Margin (Excl OI)
21.18%
4.14%
23.1%
29.71%
25.06%
20.43%
29.17%
Gross Profit Margin
24.26%
3.89%
27.04%
31.63%
17.94%
7.9%
39.58%
PAT Margin
15.64%
1.38%
16.43%
20.86%
11.01%
8.42%
28.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 16.49% vs 30.37% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 65.38% vs -31.94% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -1.48% vs 97.20% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -100.00% vs 3,723.08% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Neurocrine Biosciences, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
687.50
611.09
76.41
12.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
687.50
611.09
76.41
12.50%
Raw Material Cost
11.30
163.40
-152.10
-93.08%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
58.86
-58.86
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
5.23
-5.23
-100.00%
Selling and Distribution Expenses
286.30
127.72
158.58
124.16%
Other Expenses
24.43
14.03
10.40
74.13%
Total Expenditure (Excl Depreciation)
541.90
495.51
46.39
9.36%
Operating Profit (PBDIT) excl Other Income
145.60
115.58
30.02
25.97%
Other Income
20.60
6.57
14.03
213.55%
Operating Profit (PBDIT)
173.50
137.01
36.49
26.63%
Interest
0.00
5.23
-5.23
-100.00%
Exceptional Items
-6.70
36.72
-43.42
-118.25%
Gross Profit (PBDT)
676.20
447.69
228.51
51.04%
Depreciation
7.30
14.86
-7.56
-50.87%
Profit Before Tax
159.50
153.64
5.86
3.81%
Tax
52.00
-43.25
95.25
220.23%
Provisions and contingencies
0
0
0.00
Profit After Tax
107.50
196.89
-89.39
-45.40%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
107.50
196.89
-89.39
-45.40%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
107.50
196.89
-89.39
-45.40%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,694.30
1,357.38
1,336.92
98.49%
Earnings per share (EPS)
1.06
1.89
-0.83
-43.92%
Diluted Earnings per share
1.06
1.89
-0.83
-43.92%
Operating Profit Margin (Excl OI)
21.18%
18.91%
0.00
2.27%
Gross Profit Margin
24.26%
27.57%
0.00
-3.31%
PAT Margin
15.64%
32.22%
0.00
-16.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 68.75 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 20.07% vs -8.78% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 16.49% vs 30.37% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.75 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 1,260.76% vs -92.34% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 65.38% vs -31.94% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.29 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 388.50% vs -79.42% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.48% vs 97.20% in Jun 2024
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.18%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
